AS
ASND•United States•Healthcare•United States•$13.87B
Ascendis Pharma AS (ASND) Earnings History
Quarterly EPS estimates vs. actual results, beat/miss track record, and upcoming earnings report dates.
Reports Tracked
1
Beat Rate
0%
0B / 1M / 0=
Avg Surprise
-100.0%
Last Report
Apr 30, 2026
Reported Earnings
| Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Apr 30, 2026 | $0.39 | $0.00 | -100.0% | Miss |
Data sourced from EODHD earnings calendar. Estimates represent consensus analyst expectations where available.